PSTTF
Prescient Therapeutics Limited

4
Mkt Cap
$51.52M
Volume
0.00
52W High
$0.145
52W Low
$0.145
PE Ratio
-22.31
PSTTF Fundamentals
Price
$0.145
Prev Close
$0.16
50D MA
$0.145
Beta
0.00
Avg. Volume
0.00
EPS (Annual)
-$0.0059
P/B
6.73
Loading...
Loading...
Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded on May 22, 1986, and is headquartered in South Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Prescient Therapeutics Limited?
What is the 52-week high for Prescient Therapeutics Limited?
What is the 52-week low for Prescient Therapeutics Limited?
What is Prescient Therapeutics Limited stock price today?
What was Prescient Therapeutics Limited stock price yesterday?
What is the PE ratio of Prescient Therapeutics Limited?
What is the Price-to-Book ratio of Prescient Therapeutics Limited?
What is the 50-day moving average of Prescient Therapeutics Limited?

Latest PSTTF News

View
No PSTTF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.